JPS57159712A - Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug - Google Patents
Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drugInfo
- Publication number
- JPS57159712A JPS57159712A JP4307381A JP4307381A JPS57159712A JP S57159712 A JPS57159712 A JP S57159712A JP 4307381 A JP4307381 A JP 4307381A JP 4307381 A JP4307381 A JP 4307381A JP S57159712 A JPS57159712 A JP S57159712A
- Authority
- JP
- Japan
- Prior art keywords
- sempervirine
- alstonine
- serpentine
- drug
- activity against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4307381A JPS57159712A (en) | 1981-03-24 | 1981-03-24 | Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4307381A JPS57159712A (en) | 1981-03-24 | 1981-03-24 | Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57159712A true JPS57159712A (en) | 1982-10-01 |
Family
ID=12653668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4307381A Pending JPS57159712A (en) | 1981-03-24 | 1981-03-24 | Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57159712A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005112964A1 (en) * | 2004-05-19 | 2005-12-01 | Natural Source International | Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2450607A2 (en) * | 1978-03-13 | 1980-10-03 | Beljanski Mirko | Antiviral, anticancer, antitumour flavopereirine compsn. - activity tests for semperverine, serpentine and alstonine are also given |
-
1981
- 1981-03-24 JP JP4307381A patent/JPS57159712A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2450607A2 (en) * | 1978-03-13 | 1980-10-03 | Beljanski Mirko | Antiviral, anticancer, antitumour flavopereirine compsn. - activity tests for semperverine, serpentine and alstonine are also given |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005112964A1 (en) * | 2004-05-19 | 2005-12-01 | Natural Source International | Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer |
JP2007538093A (en) * | 2004-05-19 | 2007-12-27 | ナチュラル ソース インターナショナル | Combination of flavopereirin and alstonine in the treatment and prevention of prostate cancer |
US7341749B2 (en) * | 2004-05-19 | 2008-03-11 | Natural Source International Ltd. | Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU547007B2 (en) | Percutaneous drug therapy with skin permeability enhancer | |
GB2158829B (en) | Human tumor necrosis factor and dna therefor | |
NZ223372A (en) | Drug-containing jellifiable pellets | |
EP0659209A4 (en) | Cancer therapy utilizing malignant cells. | |
AU4595985A (en) | Cancer treatment | |
EP0070906A4 (en) | Human interferon-beta gene. | |
AU559983B2 (en) | Platinum complexes, treatment of cancer | |
AU581555B2 (en) | Tumor localization and therapy | |
JPS572296A (en) | Platinum organic complex, manufacture and malignant tumor medicine | |
EP0216938A4 (en) | Hydrotreatment catalyst. | |
NO862353L (en) | HUMAN TUMOR CANCER FACTOR. | |
JPS57192366A (en) | Acylquinolinone derivative, manufacture, drug blend containing same and use | |
AU588862B2 (en) | Human tumor therapy | |
AR242389A1 (en) | Imidazoquinazoline derivatives, their preparation and medicaments containing them | |
AU5912886A (en) | Tumor treatment in warm-blooded animals | |
EP0204831A4 (en) | Therapeutic agent delivery system. | |
GB8527159D0 (en) | Tumour therapy | |
DE3279834D1 (en) | 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression | |
JPS57159712A (en) | Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug | |
JPS57165307A (en) | Vermicides, manufacture and use | |
EP0345356A4 (en) | Platinum complex and therapeutic agent for malignant tumor | |
GB2172558B (en) | Co-ordinative rotatable supports. | |
IL79350A0 (en) | Triazole derivatives,their manufacture and their use as pesticides | |
JPS55151515A (en) | Cancer treating drug and its manufacture | |
ZA857906B (en) | Human tumor necrosis factor |